Breaking News Instant updates and real-time market news.

ACN

Accenture

$156.20

-2.76 (-1.74%)

, T

AT&T

$32.50

-0.06 (-0.18%)

17:37
10/18/18
10/18
17:37
10/18/18
17:37

CACI, IBM, Northrop Grumman and more compete for orders on $37.4B Army contract

Accenture Federal Services (ACN), AT&T Government Solutions (T), CACI Technologies (CACI), HII Mission Driven Innovative Solutions (HII), Comtech Mobile Datacom (CMTL), IBM (IBM), Jacobs Technology (JEC),Kforce Government Solutions (KFRC), L-3 Communications Integrated Systems (LLL), Leidos (LDOS), Northrop Grumman Systems (NOC), Raytheon (RTN), KEYW (KEYW) and VSE Corp. (VSEC) will compete for each order of the $37.4B hybrid contract to provide knowledge based professional engineering support services for programs with command, control, communications, computers, intelligence, surveillance, and reconnaissance, or C4ISR, related requirements. Bids were solicited via the internet with 388 received. Work locations and funding will be determined with each order, with an estimated completion date of May 14 2022. U.S. Army Contracting Command is the contracting activity.

ACN

Accenture

$156.20

-2.76 (-1.74%)

T

AT&T

$32.50

-0.06 (-0.18%)

CACI

CACI

$181.34

-2.07 (-1.13%)

HII

Huntington Ingalls

$233.27

0.15 (0.06%)

CMTL

Comtech

$32.05

-0.95 (-2.88%)

IBM

IBM

$130.52

-3.53 (-2.63%)

JEC

Jacobs Engineering

$73.01

-0.89 (-1.20%)

KFRC

Kforce

$35.15

-0.49 (-1.37%)

LLL

L3 Technologies

$218.17

-1.965 (-0.89%)

LDOS

Leidos

$66.72

-0.97 (-1.43%)

NOC

Northrop Grumman

$308.21

-1.04 (-0.34%)

RTN

Raytheon

$191.62

-1.48 (-0.77%)

KEYW

KEYW

$8.31

-0.27 (-3.15%)

VSEC

VSE Corp.

$30.75

-1.13 (-3.54%)

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 03

    Mar

ACN Accenture
$156.20

-2.76 (-1.74%)

10/04/18
MOFT
10/04/18
INITIATION
Target $200
MOFT
Buy
Accenture initiated with a Buy at MoffettNathanson
MoffettNathanson initiated Accenture with a Buy and $200 price target.
09/28/18
FBCO
09/28/18
NO CHANGE
Target $170
FBCO
Neutral
Accenture price target raised to $170 from $160 at Credit Suisse
Credit Suisse analyst Charles Brennan maintained a Neutral rating on Accenture and raised his price target to $170 from $160 following the company's "solid" Q4 report. In a research note to investors, Brennan notes that while current momentum is strong, the announced FY19 revenue guidance is for 5%-8% growth, and while investors will assume the company will hit the high end of this range, "it is hard to see" how the shares can materially re-rate on this basis with management allowing for some macro risks.
09/28/18
ARGS
09/28/18
NO CHANGE
Target $200
ARGS
Buy
Accenture price target raised to $200 from $175 at Argus
Argus analyst Jim Kelleher raised his price target on Accenture to $200 and kept his Buy rating after its Q4 results, saying that while the company guided Q1 cautiously, it is typically "very conservative" in its outlook and tends to bump up its annual guidance at every quarter. The analyst is positive on the customers' engagement of Accenture services to assist them in digital transformation, stating that its "The New" business category which includes digital / cloud / security saw a "strong" double digit" annual growth. Kelleher adds that the company's premium valuation relative to its peer group is warranted by its "rising revenue and new orders, strong cash-growth trends, market-share gains, and increasing profitability".
10/01/18
RHCO
10/01/18
NO CHANGE
Target $178
RHCO
Hold
Accenture price target raised to $178 from $168 at SunTrust
SunTrust analyst Frank Atkins raised his price target on Accenture to $178, citing the "continued solid traction" in the company's digital segment while also reflecting the adjustments made for accounting and tax changes. Although the analyst believes that the company "deserves a premium" to its peer group thanks to its "strong rotation to digital" and "superior diversification", he sees near-term consensus estimates as fair. Atkins keeps his Hold rating on Accenture.
T AT&T
$32.50

-0.06 (-0.18%)

09/25/18
MKMP
09/25/18
NO CHANGE
Target $7.5
MKMP
Buy
Nokia gaining 5G market share with AT&T, says MKM Partners
MKM Partners analyst Michael Genovese kept his Buy rating and $7.50 price target on Nokia (NOK), saying his checks indicate that the company has "gained significant 5G base station market share at AT&T (T) at Ericsson's (ERIC) expense". The analyst notes that while 4G/LTE market share at AT&T was 65% Ericsson and 35% Nokia, the 5G Wireless Access infrastructure market share is likely at 65% Nokia and 35% Samsung (SSNLF). Genovese sees Nokia becoming the "prime infrastructure vendor" heading into 2019 - the year of "major positive global inflection for 5G".
09/24/18
DBAB
09/24/18
NO CHANGE
DBAB
Buy
Deutsche Bank adds AT&T to Catalyst Call Buy list
Deutsche Bank analyst Matthew Niknam added AT&T to his firm's Catalyst Call Buy list saying he sees an "attractive setup" for the stock ahead of the company's Q3 results. The analyst sees "improving second derivative trends" in AT&T's two biggest segments this quarter, or Wireless and Entertainment Group. He believes the company can post upside to consensus earnings and free cash flow expectations for both Q3 and future periods and keeps a Buy rating on the shares.
10/05/18
NOMU
10/05/18
DOWNGRADE
Target $31
NOMU
Neutral
Nomura Instinet downgrades CommScope to Neutral with $31 price target
Nomura Instinet analyst Jeffrey Kvaal downgraded CommScope (COMM) to Neutral from Buy and lowered his price target for the shares to $31 from $35. The analyst continues to view CommScope as a long-term beneficiary of both mobile and fiber spending growth. However, he believes that current tailwinds "appear less muscular than hoped." While CommScope and AT&T (T) initially planned to reach 15,000 towers with its FirstNet build by September 2018, that plan has softened to 15,000 by March 2019, Kvaal tells investors in a research note. He expects Q2 to prove the peak of FirstNet spending until mid-2019.
10/18/18
NEED
10/18/18
NO CHANGE
Target $17
NEED
Buy
Adtran price target lowered to $17 at Needham on Q3 revenue slip
Needham analyst Richard Valera nudged his price target on Adtran (ADTN) lower to $17 from $18 and also lowered his FY19 EPS view to 15c from 42c after its Q3 revenues came in "light due to an explainable slip out of shipments to NBN". The analyst also notes the management's more downbeat view of its G.Fast program with AT&T (T), along with a generally more muted outlook for next year. Valera keeps a Buy on Adtran however, stating that although the stock is setting new 52-week lows on a series of disappointments, its valuation multiple of 1.1-times enterprise value to expected 2018 sales is supportive of the rating.
CACI CACI
$181.34

-2.07 (-1.13%)

09/25/18
JEFF
09/25/18
DOWNGRADE
Target $190
JEFF
Hold
CACI downgraded to Hold from Buy at Jefferies
Jefferies analyst Sheila Kahyaoglu downgraded CACI (CACI) to Hold and lowered her price target for the shares to $190 from $222. While the company is on a path of accelerated growth, the recent rise in shares largely captures the upside, Kahyaoglu tells investors in a research note. Further, she believes CACI "would appear to be the odd man out" regarding industry consolidation following SAIC's (SAIC) acquisition of Engility (EGL). The analyst believes this could weigh on CACI's valuation and estimates. Kahyaoglu thinks a lot of near-term catalysts should keep the shares range-bound. The analyst coupled the downgrade with an upgrade of SAIC to Buy.
08/20/18
LOOP
08/20/18
NO CHANGE
Target $210
LOOP
Buy
CACI latest guidance increasingly seen as 'conservative', says Loop Capital
Loop Capital analyst Joseph Vafi keeps his Buy rating and $210 price target on CACI (CACI), but notes that the company's latest guidance is likely to be even more conservative than he previously assumed after it confirmed the acquisition of certain Navy contracts from General Dynamics (GD). Vafi says he will look for any potential 8K filing disclosures from General Dynamics on the size of its Seaport-e business, which had booked those contracts, in 2017, and estimates as much as over $30M in conservatism related to CACI's FY19 revenue outlook.
08/17/18
NBLE
08/17/18
DOWNGRADE
NBLE
Hold
CACI downgraded to Hold from Buy at Noble Financial
08/17/18
RILY
08/17/18
NO CHANGE
Target $182
RILY
Neutral
CACI price target raised to $182 from $165 at B. Riley FBR
B. Riley FBR analyst Christopher Van Horn reiterated a Neutral rating on CACI but raised his price target to $182 from $165, citing Q4 earnings and FY19 guidance that came in above expectations and future expectations that have moved "a bit higher" since the announcement that it completed the acquisition of SE&A BU. The analyst expects CACI to continue examining possible tuck-in acquisitions and says the company may also pursue larger and more transformative deals.
HII Huntington Ingalls
$233.27

0.15 (0.06%)

10/11/18
10/11/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JPMORGAN UPGRADES LUMENTUM AFTER SELLOFF: JPMorgan analyst Samik Chatterjee upgraded Lumentum (LITE) to Overweight from Neutral with an unchanged price target of $80. The 19% stock decline from the highs in late August, driven by concerns relative to U.S.-China trade, over-appreciates the "modest risks" for Lumentum, Chatterjee said. He believes this creates an "attractive buying opportunity" to capitalize on the near-term improvement in the earnings outlook. GOLDMAN CUTS HUNTINGTON TO SELL: Goldman Sachs analyst Noah Poponak downgraded Huntington Ingalls Industries (HII) to Sell from Neutral and lowered his price target for the shares to $208 from $220. Poponak said Huntington is now the most expensive stock in his Defense coverage on economic, price-to-earnings and free cash flow yield. The analyst believes the stock could underperform Defense peers in the medium-term given the valuation. JEFFRIES STARTS HERBALIFE WITH A BUY: Jefferies analyst Akshay Jagdale started Herbalife Nutrition (HLF) with a Buy rating and $65 price target. After a period of "muted growth," Herbalife's sales looked poised to accelerate to a more normalized range of 5%-9%, Jagdale believes. He thinks the company should be able to grow at least in line with its total addressable market growth rate of 6%. This, coupled with margin expansion and accretive free cash flow usage, should drive "significant" earnings upside and support a "growth company valuation," Jagdale said. JPMORGAN RAISES PRICE TARGET ON NY TIMES: JPMorgan analyst Alexia Quadrani raised her price target for New York Times (NYT) to $32 and reiterated an Overweight rating on the shares ahead of the company's Q3 results. The analyst said that while quarterly subscriber growth may continue to be volatile, the company's longer-term trends are positive. She expects New York Times' growth to "remain at elevated levels for the foreseeable future." SNAP PRICE TARGET CUT AT GOLDMAN SACHS: Goldman Sachs analyst Heath Terry lowered his price target for Snap (SNAP) to $11 from $17, while reiterating a Buy rating on the shares. With Snap shares down 50% since the company reported Q2 results, beyond the broader weakness in social media, the analyst believes investors are clearly focused on the impact competition is having on the company's user growth, ability to monetize, and capital needs. Terry continues to believe that a Twitter-like (TWTR) turnaround is possible, particularly as the new Android app comes out of Alpha later this quarter. However, it is unlikely that Q3 results will show any signs of that as reported DAUs decline and engagement is negatively impacted by the redesign/competition, he said.
10/11/18
10/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Huntington Ingalls (HII) downgraded to Sell from Neutral at Goldman Sachs with analyst Noah Poponak saying the company's pace of growth may not support current valuation levels. 2. Ferrari (RACE) downgraded to Hold from Buy at Jefferies with analyst Philippe Jean Houchois saying he re-based his expectations lower to reflect higher upfront investments and a lower quality of earnings as management's new strategy of less volume and more exclusivity takes hold. 3. Valero (VLO) downgraded to Hold from Buy at Tudor Pickering. 4. TransDigm (TDG) downgraded to Neutral from Outperform at Baird with analyst Peter Arment saying the Esterline (ESL) deal is a shift in the company's strategy in buying a "fixer-up asset" with significantly below average returns that will take time to improve. He believes it will be an overhang on the stock near-term. Arment maintained his $365 price target on TransDigm shares. 5. Tata Motors (TTM) downgraded to Hold from Buy at HSBC with analyst Amyn Pirani saying while the company's India business has surprised positively, Jaguar Land Rover's volumes have continued to decline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/18
GSCO
10/11/18
DOWNGRADE
Target $208
GSCO
Sell
Goldman calls Huntington most expensive in Defense, downgrades to Sell
Goldman Sachs analyst Noah Poponak downgraded Huntington Ingalls Industries to Sell from Neutral and lowered his price target for the shares to $208 from $220. Poponak says Huntington is now the most expensive stock in his Defense coverage on economic, price-to-earnings and free cash flow yield. The analyst believes the stock could underperform Defense peers in the medium-term given the valuation. Further, he sees risks to each of revenue growth, margin levels, and free cash versus market expectations, and expects Huntington's earnings to decline in 2019.
10/11/18
GSCO
10/11/18
DOWNGRADE
Target $208
GSCO
Sell
Huntington Ingalls downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Noah Poponak downgraded Huntington Ingalls Industries to Sell and lowered his price target for the shares to $208 from $220. The company's pace of growth may not support current valuation levels, Poponak tells investors in a research note.
CMTL Comtech
$32.05

-0.95 (-2.88%)

09/28/18
BMOC
09/28/18
NO CHANGE
Target $40
BMOC
Outperform
Comtech price target raised to $40 from $37 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Comtech to $40 after its Q4 results, saying the quarter was "mostly positive" in spite of the top-line miss. The analyst points to better than expected earnings and gross margins along with new record highs in backlog, which adds to revenue visibility. Long added that the potential for Comtech to top $1B in sales "highlights strong demand" across its portfolio. The analyst anticipates the company's success in its products, including the "rapidly growing" Heights and BFT2 platforms, to continue into FY19.
05/17/18
05/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Costco (COST) initiated with a Buy at Loop Capital. 2. Align Technology (ALGN) initiated with an Outperform at Evercore ISI. 3. Baxter (BAX) assumed with an Overweight at Piper Jaffray. 4. Comtech (CMTL) initiated with a Neutral at Citi. 5. Helius Medical (HSDT) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/18
SBSH
05/17/18
INITIATION
Target $33
SBSH
Neutral
Comtech initiated with a Neutral at Citi
Citi analyst Asiya Merchant started Comtech Telecommunications with a Neutral rating and $33 price target. End market visibility, pricing pressures from end customers and CEO succession plans remain a "viable concern," Merchant tells investors in a research note. Further, the analyst believes the market has already priced in the positives from recent strength in the company's backlog.
03/09/18
BMOC
03/09/18
NO CHANGE
Target $35
BMOC
Outperform
Comtech price target raised to $35 from $26 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Comtech to $35 after the company's Q2 earnings beat and raised FY18 guidance. Long also points to Comtech's backlog reaching "near-record levels", which he sees as particularly impressive in light of management's conservative exclusion of unfunded contracts. The analyst keeps his Outperform rating, also anticipating Comtech's return to growth in the government business.
IBM IBM
$130.52

-3.53 (-2.63%)

10/18/18
10/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. IBM (IBM) downgraded to Hold from Buy at Argus with analyst James Kelleher saying the company's growth prospects are "fading." 2. Gap (GPS) downgraded to Underweight from Neutral at JPMorgan with analyst Matthew Boss saying the timeframe for sequential same-store-sales improvement at the Gap brand and a return to the "momentum" last seen in the second half of 2017 is now less certain as the brand grapples with operational issues and an "assortment imbalance." 3. Yum! Brands (YUM) downgraded to In Line from Outperform at Evercore ISI with analyst Matt McGinley saying the recent move in shares have placed its valuation closer to the top of its peer franchised peers. 4. EnLink Midstream Partners (ENLK) downgraded to Neutral from Buy at Citi with analyst Mirek Zak citing valuation. 5. Wingstop (WING) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst John Glass citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/18
WEDB
10/18/18
NO CHANGE
Target $165
WEDB
Neutral
IBM price target lowered to $165 from $185 at Wedbush
Wedbush analyst Moshe Katri lowered his price target for IBM to $165 from $185 after the company reported mixed Q3/CY18 results as the "growth" areas at IBM, namely Strategic Imperatives, Cognitive and Cloud are yet to show growth consistency/acceleration while profitability performance also remains unconvincing. The analyst continues to believe that only undertaking the difficult path of aggressively terminating/restructuring underperforming units, hence, sacrificing top-line growth for generating margin/free cash flow improvements will likely generate significant return to shareholders. Katri reiterates a Neutral rating on the shares.
10/18/18
ARGS
10/18/18
DOWNGRADE
ARGS
Hold
IBM downgraded to Hold at Argus on 'fading growth prospects'
As noted earlier, Argus analyst James Kelleher downgraded IBM to Hold after its Q3 revenue miss, saying the company's growth prospects are "fading". The analyst notes that revenues have "flipped back to negative" while margin in key business segments have shrunk. Kelleher adds that even though the stock is trading at a discount, a Hold rating is "appropriate" until the company can show "consistent top-line growth, margin expansion, and earnings acceleration".
10/18/18
ARGS
10/18/18
DOWNGRADE
ARGS
Hold
IBM downgraded to Hold from Buy at Argus
JEC Jacobs Engineering
$73.01

-0.89 (-1.20%)

08/07/18
KEYB
08/07/18
NO CHANGE
Target $80
KEYB
Overweight
Jacobs Engineering price target raised to $80 from $75 at KeyBanc
KeyBanc analyst Tahira Afzal raised his price target for Jacobs Engineering to $80 from $75 following Q3 results. The analyst views the Q3 beat and stronger than expected initial FY19 guidance as further evidence of the EPS power. Afzal views further upside as possible given the strong momentum in the company's high-margin end markets and increased focus on profitable growth. He reiterates an Overweight rating on the shares.
08/07/18
BARD
08/07/18
NO CHANGE
Target $82
BARD
Outperform
Jacobs Engineering price target raised to $82 from $73 at Baird
Baird analyst Andrew Wittmann raised his price target on Jacobs Engineering to $82 from $73 following its Q2 results. The analyst said his conviction is moderating against the recent outperformance of the shares as the earnings may have overstated the underlying gains in the business. Wittmann reiterated his Outperform rating on Jacobs Engineering shares.
09/06/18
MKMP
09/06/18
NO CHANGE
Target $84
MKMP
Buy
Jacobs Engineering price target raised to $84 from $79 at MKM Partners
MKM Partners analyst Daniel Scott raised his price target on Jacobs Engineering to $84 and kept his Buy rating, saying the stock price has rallied 29% since his upgrade in March. The analyst also cites the company's increased outlook for CH2M acquisition synergy guidance along with sequentially rising backlog. Scott further notes that valuation on Jacobs Engineering is attractive at 13.7-times his expected forward earnings vs. 14.0-times peer group average. The analyst believes some upside to guidance for the first half of 2019 is possible on the "announced wins this quarter".
10/11/18
10/11/18
NO CHANGE

Jacobs Engineering selected by Sirius Minerals for EPC contract in England
Jacobs Engineering received an engineering, procurement and construction contract from Sirius Minerals for its new materials handling facility in Teesside, England. The MHF is being constructed as part of the company's North Yorkshire Polyhalite Project, which will supply a unique type of potash fertilizer.
KFRC Kforce
$35.15

-0.49 (-1.37%)

08/02/18
RHCO
08/02/18
NO CHANGE
Target $44
RHCO
Hold
Kforce price target raised to $44 from $29 at SunTrust
SunTrust analyst Tobey Sommer raised his price target on Kforce to $44 after its "encouraging" Q2 results, saying the company remains on track to reach its long-term operating margin goal. Sommer noted the company's main Tech Flex segment revenue rising 9.8% - about 3 times faster than the projected industry growth. The analyst also kept his Hold rating on Kforce citing valuation.
08/10/18
FBCO
08/10/18
INITIATION
Target $38
FBCO
Neutral
Kforce initiated with a Neutral at Credit Suisse
Credit Suisse analyst Kevin McVeigh initiated the Business and Professional Services sector, starting Kforce with a Neutral rating and $38 price target, citing valuation well above the late-cycle average and a balanced risk/reward profile.
06/01/18
NRCS
06/01/18
DOWNGRADE
NRCS
Neutral
Kforce downgraded to Neutral from Buy at Northcoast
06/01/18
06/01/18
DOWNGRADE

Neutral
Kforce downgraded to Neutral, risk/reward balanced, says Northcoast
As previously reported, Northcoast downgraded Kforce to Neutral from Buy with a $33 price target. Analyst John Healy said shares have been strong over the past few months and risk/reward is more balanced.
LLL L3 Technologies
$218.17

-1.965 (-0.89%)

10/15/18
FBCO
10/15/18
NO CHANGE
Target $209
FBCO
Outperform
Harris price target raised to $209 from $190 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Harris (HRS) to $209 from $190 after the company and L3 Technologies (LLL) announced an all-stock merger of equals. The analyst believes this could be "the most strategically significant and shareholder friendly" M&A deal announced since the start of the current A&D consolidation wave. He reiterates an Outperform rating on Harris' shares.
10/15/18
FBCO
10/15/18
NO CHANGE
Target $272
FBCO
Outperform
L3 Technologies price target raised to $272 from $238 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for L3 Technologies (LLL) to $272 from $238 after the company and Harris (HRS) announced an all-stock merger of equals. Though some may read into Harris buying L3 Technologies, the analyst sees this as a true merger of equals. He reiterates an Outperform rating on L3 Technologies' shares.
10/16/18
RHCO
10/16/18
NO CHANGE
Target $268
RHCO
Buy
L3 Technologies price target raised to $268 from $253 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on L3 Technologies (LLL) to $268 and kept his Buy rating after the company's merger announcement with Harris (HRS). The analyst expects the merger to result in a more "cost competitive, highly concentrated, player in the platform agnostic defense electronics market" and also anticipates cost and revenue synergies to be "anchored and back tested" by the latter's 2015 Exelis acquisition.
10/15/18
JEFF
10/15/18
NO CHANGE
Target $184
JEFF
Buy
Harris, L3 should trade up 5% on merger deal, says Jefferies
Jefferies analyst Sheila Kahyaoglu believes both Harris (HRS) and L3 Technologies (LLL) should trade up 5% following the announced merger of equals. The analyst bases this on the combined company's $3B of free cash flow generation in 2022and a 6.5% free cash flow yield, discounted back. She has a Buy rating on Harris and Hold rating on L3. Harris in premarket trading is up 5.4% to $163.25 while L3 is up 6.7% to $208.89.
LDOS Leidos
$66.72

-0.97 (-1.43%)

04/23/18
SBSH
04/23/18
UPGRADE
Target $71
SBSH
Buy
Citi upgrades Cerner to Buy on government EHR opportunity
Citi analyst Stephanie Demko upgraded Cerner (CERN) to Buy from Neutral with an unchanged price target of $71. The Department of Defense and Veterans Affairs are embarking on electronic health records upgrade projects worth greater than $14B, which is good for both Cerner and Leidos Holdings (LDOS), Demko tells investors in a research note. The analyst raised her price target for Leidos to $80 from $75 and keeps a Buy rating on the shares. Demko says contract delays at Veterans Affairs are an unfortunate, but normal, part of the government process. She believes both companies will address the critical needs facing the government.
05/08/18
GSCO
05/08/18
DOWNGRADE
GSCO
Buy
Leidos downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Noah Poponak removed Leidos from his firm's Conviction List but keeps a Buy rating on the shares. The "moving targets and lack of consistency in working capital" on the cash flow statement have been surprising to the downside, Poponak tells investors in a research note. He notes Leidos has had four consecutive quarters of organic revenue decline. The analyst points out that, however, that Leidos is the least expensive Defense stock he covers. Poponak has an $82 price target for the shares.
06/21/18
WELS
06/21/18
NO CHANGE
WELS
Leidos may have opportunity to regain lost TSA business, says Wells Fargo
After the Washington Business Journal reported that the Transportation Security Administration has terminated a $578M contract awarded to Peraton, Wells Fargo analyst Ed Caso noted that Leidos is the incumbent providing logistical support services for security screening equipment. If the contract goes back to rebid, Leidos' transition agreement will likely need to be extended further and the company may have an opportunity to recapture the "notable" loss, added Caso, who has an Outperform rating on Leidos shares.
06/18/18
GSCO
06/18/18
DOWNGRADE
Target $71
GSCO
Neutral
Leidos downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Noah Poponak downgraded Leidos to Neutral and lowered his price target for the shares to $71 from $82. The analyst cites "diminished confidence" in future estimates for his downgrade to Neutral.
NOC Northrop Grumman
$308.21

-1.04 (-0.34%)

09/21/18
MSCO
09/21/18
NO CHANGE
MSCO
Morgan Stanley says not to panic over Defense payment proposal
Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, firstly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Even if it were to move forward, the proposal primarily impacts cash flow timing, with underlying earnings unchanged and potential offsets evident, Lalwani tells investors. Lastly, while there would be considerable uncertainty around rule implementation, the proposal would create a path to superior cash flows versus today, the analyst added. Companies in the defense contracting space include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
08/15/18
UBSW
08/15/18
INITIATION
Target $315
UBSW
Neutral
Northrop Grumman initiated with a Neutral at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Northrop Grumman with a Neutral rating and $315 price target.
07/31/18
07/31/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Neutral from Reduce at Nomura Instinet analyst Mark Kelley saying after selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset. 2. Chipotle (CMG) upgraded to Buy from Hold at Jefferies with analyst Andy Barish saying he believes Chipotle is one of the better positioned companies to benefit from the ongoing shift to digital/off-premise. 3. Affiliated Managers (AMG) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying he believes the company is positioned for "at least" modest organic growth. 4. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the Q1 report was "stellar," beating every key metric, while the share reaction was "lukewarm." 5. Northrop Grumman (NOC) upgraded to Buy on valuation at Buckingham with analyst Richard Safran saying the sell-off following the Q2 report provides an investment opportunity telling investors Defense spending and recent program wins may not be fully reflected in consensus expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RTN Raytheon
$191.62

-1.48 (-0.77%)

08/15/18
UBSW
08/15/18
INITIATION
Target $250
UBSW
Buy
Raytheon initiated with a Buy at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Raytheon with a Buy rating and $250 price target.
05/24/18
STFL
05/24/18
NO CHANGE
Target $65
STFL
Buy
AeroVironment well-positioned to win new Army contract, says Stifel
Separate from AeroVironment's (AVAV) recent Switchblade contract announcement, Stifel analyst Joseph DeNardi highlighted that the Army recently posted a request for information for Switchblade production from FY19-FY26. DeNardi said it is unclear what the likelihood is that AeroVironment continues to be the sole-source Switchblade provider as it has been from FY17-FY19, as he assumes multiple contractors will reply and suspects that offerings presumably from companies like Raytheon (RTN), Textron (TXT) and possibly Lockheed (LMT) will be more mature than they were a few years ago. Still, he is encouraged by the length of the performance period for the new RFI and views AeroVironment as well-positioned to win the competition, DeNardi tells investors. He keeps a Buy rating and $65 price target on the stock.
KEYW KEYW
$8.31

-0.27 (-3.15%)

10/01/18
10/01/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. KEYW (KEYW) initiated with an Outperform at William Blair. 2. Garrett Motion (GTX) initiated with an Underperform at RBC Capital. 3. WillScot (WSC) initiated with an Overweight at Morgan Stanley. 4. Bitauto (BITA) resumed with a Hold at 86 Research. 5. SB One Bancorp (SBBX) initiated with an Outperform at Boenning & Scattergood. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/18
DRXL
08/01/18
DOWNGRADE
DRXL
Hold
KEYW downgraded to Hold from Buy at Drexel Hamilton
Drexel Hamilton analyst Brian Ruttenbur downgraded KEYW to Hold from Buy saying the announced modification of one of its largest programs for flight services could be a 2019 headwind. Rutternbur said this contract contributes roughly $80M-100M annually and $10M- $15M of EBITDA and has concerns about growth.
10/01/18
WBLR
10/01/18
INITIATION
WBLR
Outperform
KEYW initiated with an Outperform at William Blair
William Blair analyst Louie DiPalma started KEYW with an Outperform rating.
10/01/18
WBLR
10/01/18
INITIATION
WBLR
Outperform
William Blair starts KEYW at Outperform, says shares can top $10
William Blair analyst Louie DiPalma started KEYW with an Outperform rating. Despite competition from large government IT contractors, KEYW has differentiated itself with a unique set of geospatial, cyber, and analytics services for U.S. Intelligence Community customers, DiPalma tells investors in a research note. The analyst does not believe the stock's current valuation takes into account how the company's assets are "strategically aligned for future trends." He thinks KEYW's equity can be greater than $10 per share in 12 months. The stock in premarket trading is up 28c to $8.94.
VSEC VSE Corp.
$30.75

-1.13 (-3.54%)

TODAY'S FREE FLY STORIES

PDVW

pdvWireless

$39.84

0.06 (0.15%)

16:30
11/17/18
11/17
16:30
11/17/18
16:30
Conference/Events
pdvWireless management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.49

0.23 (0.40%)

16:28
11/17/18
11/17
16:28
11/17/18
16:28
Conference/Events
CBS management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

THS

TreeHouse

$51.92

0.72 (1.41%)

, CAG

Conagra Brands

$33.09

0.66 (2.04%)

12:54
11/17/18
11/17
12:54
11/17/18
12:54
Periodicals
Treehouse Foods stock may have room to gain, Barron's says »

Treehouse Foods (THS)…

THS

TreeHouse

$51.92

0.72 (1.41%)

CAG

Conagra Brands

$33.09

0.66 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$194.23

1.83 (0.95%)

12:51
11/17/18
11/17
12:51
11/17/18
12:51
Periodicals
Amgen may be 'a remedy' for tougher times, Barron's says »

Amgen may be a stock that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

AAPL

Apple

$193.42

2 (1.04%)

, LITE

Lumentum

$41.50

0.46 (1.12%)

12:47
11/17/18
11/17
12:47
11/17/18
12:47
Periodicals
Apple stock could continue to slide, Barron's says »

Apple's (AAPL) stock…

AAPL

Apple

$193.42

2 (1.04%)

LITE

Lumentum

$41.50

0.46 (1.12%)

QRVO

Qorvo

$66.32

1.18 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$56.39

0.9 (1.62%)

, RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

12:41
11/17/18
11/17
12:41
11/17/18
12:41
Periodicals
Investors may find bargains among oil, natural gas stocks, Barron's says »

Investors have been…

APC

Anadarko

$56.39

0.9 (1.62%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

CVX

Chevron

$119.14

2.18 (1.86%)

BP

BP

$40.85

-0.3 (-0.73%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Jan

  • 22

    Jan

LB

L Brands

$35.28

-0.41 (-1.15%)

, JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

12:34
11/17/18
11/17
12:34
11/17/18
12:34
Periodicals
Kohl's, Target set to thrive this holiday season, Barron's says »

Store chains have been…

LB

L Brands

$35.28

-0.41 (-1.15%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

TJX

TJX

$51.47

-0.98 (-1.87%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TIF

Tiffany

$106.48

0.52 (0.49%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TGT

Target

$79.67

-1.09 (-1.35%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

T

AT&T

$30.30

0.18 (0.60%)

, FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

09:18
11/17/18
11/17
09:18
11/17/18
09:18
OnTheFly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

T

AT&T

$30.30

0.18 (0.60%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

CMCSA

Comcast

$38.60

0.11 (0.29%)

CMCSK

Comcast

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.46

-0.12 (-0.72%)

F

Ford

$9.05

-0.26 (-2.79%)

GM

General Motors

$35.76

0.21 (0.59%)

HMC

Honda

$28.21

0.01 (0.04%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$116.87

-0.02 (-0.02%)

VLKAY

Volkswagen

$0.00

(0.00%)

NYT

New York Times

$26.30

-0.2 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/17/18
11/17
04:55
11/17/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

MSI

Motorola Solutions

$129.97

0.72 (0.56%)

18:48
11/16/18
11/16
18:48
11/16/18
18:48
Hot Stocks
Motorola Solutions: ITC confirms Hytera products infringe Motorola patents »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Dec

  • 19

    Dec

PCG

PG&E

$24.39

6.62 (37.25%)

18:23
11/16/18
11/16
18:23
11/16/18
18:23
Periodicals
CPUC isn't ruling out board shuffle, breakup for PG&E, Bloomberg says »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.04

0.05 (0.38%)

18:00
11/16/18
11/16
18:00
11/16/18
18:00
Periodicals
Barrick Gold looking to add more copper, bullion assets, Reuters reports »

Barrick Gold is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$33.05

0.165 (0.50%)

17:57
11/16/18
11/16
17:57
11/16/18
17:57
Hot Stocks
Aqua America CEO acquires over 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

, XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

17:39
11/16/18
11/16
17:39
11/16/18
17:39
General news
Week ending ETF scorecard: Real Estate leads, Consumer Discretionary slumps »

S&P500 SECTORS: Real…

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

XLU

Utilities SPDR

$54.86

0.77 (1.42%)

XLI

Industrial Select Sector SPDR

$72.00

(0.00%)

XLV

Health Care Select Sector SPDR

$92.05

0.91 (1.00%)

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

XLP

Consumer Staples Sector SPDR

$56.04

0.15 (0.27%)

XLE

Energy Select Sector SPDR

$67.23

0.76 (1.14%)

XLC

Communication Services Select Sector SPDR Fund

$44.88

-0.2 (-0.44%)

XLK

Technology Select Sector SPDR

$68.22

-0.1 (-0.15%)

XLY

Consumer Discretionary Sector SPDR

$106.37

-0.43 (-0.40%)

GLD

SPDR Gold Shares

$115.56

0.82 (0.71%)

SLV

iShares Silver Trust

$13.55

0.115 (0.86%)

USO

United States Oil Fund

$12.07

0.08 (0.67%)

UNG

United States Natural Gas Fund

$35.43

3.63 (11.42%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.24

-0.27 (-0.32%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$111.73

0.23 (0.21%)

TLT

iShares 20+ Year Treasury Bond Fund

$114.65

0.61 (0.53%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.13

0.3 (0.30%)

SHY

iShares 1-3 Year Treasury Bond

$83.13

0.08 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$17.02

0.23 (1.37%)

17:36
11/16/18
11/16
17:36
11/16/18
17:36
Hot Stocks
Aquestive receives CRL from FDA for tadalafil oral film »

Aquestive Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

DAKT

Daktronics

$7.67

0.07 (0.92%)

17:35
11/16/18
11/16
17:35
11/16/18
17:35
Hot Stocks
Daktronics adopts new shareholder rights agreement »

Daktronics announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TI

Telecom Italia

$6.02

0.12 (2.03%)

17:33
11/16/18
11/16
17:33
11/16/18
17:33
Periodicals
Gubitosi viewed as frontrunner for Telecom Italia CEO job, Reuters says »

Veteran Italian manager…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$18.77

-0.59 (-3.05%)

17:30
11/16/18
11/16
17:30
11/16/18
17:30
Hot Stocks
Maxar Technologies shareholders approve U.S. domestication »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$1.83

(0.00%)

17:28
11/16/18
11/16
17:28
11/16/18
17:28
Syndicate
Breaking Syndicate news story on Plug Power »

Plug Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$4.55

-0.02 (-0.44%)

17:22
11/16/18
11/16
17:22
11/16/18
17:22
Syndicate
Breaking Syndicate news story on GlobalSCAPE »

GlobalSCAPE files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQIX

Equinix

$388.18

2.67 (0.69%)

17:19
11/16/18
11/16
17:19
11/16/18
17:19
Hot Stocks
Equinix's Lee sells 2,792 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

LMT

Lockheed Martin

$301.06

-4.42 (-1.45%)

17:17
11/16/18
11/16
17:17
11/16/18
17:17
Hot Stocks
Lockheed Martin awarded $282.09M Naval Sea Systems Command contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$2.56

0.045 (1.79%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Hot Stocks
Teligent receives notification of deficiency from Nasdaq »

Teligent said that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$1.82

0.07 (4.00%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Syndicate
Breaking Syndicate news story on Staffing 360 Solutions »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

IMMR

Immersion

$9.56

-0.14 (-1.44%)

17:12
11/16/18
11/16
17:12
11/16/18
17:12
Hot Stocks
Breaking Hot Stocks news story on Immersion »

Man Group reports 4.84%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.